Encouraging 6-year #NATALEE results presented at #ESMO26 ! 🎯

Back to meeting Original

Back to meeting

Kristina Jankovic, MD· @JankovicK · X·2026-10-24 01:42· 3 days agoScore70

NATALEE

Body · original

Encouraging 6-year #NATALEE results presented at #ESMO26 ! 🎯

Adjuvant ribociclib + NSAI shows a deepening iDFS benefit and favourable OS results in HR+/HER2− early #BreastCancer

@OncoAlert

353 views · 5 likes · 4 reposts · 0 replies

Conference abstracts

LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage

Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes

https://esmocongress.esmo.org

引用@

Oral abstract #BreastCancer session at #ESMO26: updated data from NATALEE trial simultaneously published in @Annals_Oncology @OncoAlert @myESMO

在 X 查看被引用的帖子

Source: Kristina Jankovic, MD · x.com